Correspondence 0001493152-25-006822 from DataMeds AI, Inc. (WGRX)
DataMeds AI, Inc.
Date: Feb. 14, 2025 · CIK: 0002030763 · Accession: 0001493152-25-006822
AI Filing Summary & Sentiment
File numbers found in text: 333-280945
Show Raw Text
CORRESP
1
filename1.htm
February
14, 2025
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Trade & Services
100
F Street, N.E.
Washington
DC, 20549
Attn:
Rucha Pandit
Re:
Wellgistics
Health, Inc.
Registration
Statement on Form S-1, as amended
Registration
No. 333-280945
REQUEST
FOR ACCELERATION OF EFFECTIVENESS
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), Wellgistics Health, Inc. (the “Company”)
hereby requests that the effectiveness of the above-captioned Registration Statement, as amended (the “Registration Statement”),
be accelerated to 4:30 p.m., Eastern Standard Time, on February 14, 2025, or as soon thereafter as practicable unless we or our
outside counsel, Dykema Gossett PLLC, request by telephone that such Registration Statement be declared effective at some other time.
In
making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Securities Act.
Once
the Registration Statement is effective, please orally confirm the event with our counsel, Dykema Gossett PLLC, by calling Kate L. Bechen
at (414) 488-7321. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying
the effective time and date of the Registration Statement be sent to our counsel, Dykema Gossett PLLC, Attention: Kate L. Bechen by email
to kbechen@dykema.com.
If
you have any questions regarding this request, please contact Kate Bechen of Dykema Gossett PLLC at (414) 488-7333.
Very
truly yours,
WELLGISTICS
HEALTH, INC.
By:
/s/
Tim Canning
Name:
Tim
Canning
Title:
Chief
Executive Officer